Colon cancer

Cancer of colon and rectum, the third most common cancer in men and the second in women. Worldwide 1.8 million people are expected to be diagnosed with colon cancer in 2018.

Showing 1–9 of 90 results

EpiMelt MLH1 test assay

Homo sapiens mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli) (MLH1), NM_000249

DNA Methylation Assay Kit for MLH1 based on MS-HRM. Includes controls

EpiMelt APC test assay

Homo sapiens adenomatous polyposis coli (APC), NM_001127511

DNA Methylation Assay Kit for APC, based on MS-HRM. Includes controls.

 

EpiMelt RASSF1A test assay

Homo sapiens Ras association (RalGDS/AF-6) domain family member 1 (RASSF1), NM_170714

DNA Methylation Assay Kit for RASSF1A, based on MS-HRM. Includes controls

 

EpiMelt CDH1 test assay

Homo sapiens cadherin 1, type 1, E-cadherin (epithelial) (CDH1), NM_004360

DNA Methylation Assay Kit for CDH1, based on MS-HRM. Includes controls

 

EpiMelt CDH13 test assay

Homo sapiens cadherin 13, H-cadherin (heart) (CDH13), NM_001220492

DNA Methylation Assay Kit for CDH13, based on MS-HRM. Includes controls

 

EpiMelt ATM test assay

Homo sapiens ataxia telangiectasia mutated (ATM), NM_000051

Approximate delivery time 4 weeks